With the onset of the 21st century marked by a staggering growth in artificial intelligence (AI) capabilities, we have witnessed groundbreaking advancements and transformations across various industries.
Researchers at NYU Langone Health's Perlmutter Cancer Center and the University of Glasgow developed and tested the program. They say that because it incorporates structural features of tumors from 452 adenocarcinoma patients,
The discoveries, detailed in the June 11 online issue of Nature Genetics, reveal genetic factors impacting heart disease that open new avenues for targeted treatments and personalized approaches to cardiovascular care.
Like many conditions, epilepsy treatment starts with early detection.
Mammography successfully reduces breast cancer mortality, but also carries the risk of false-positive findings. In recent years, researchers have studied the use of AI systems in screening.